A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma NCT04996004 Leiomyosarcoma
Ontorpacept (TT...
Doxorubicin
18 Years - Pfizer View Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall NCT03651375 Sarcoma
Fibrosarcoma
Leiomyosarcoma
Liposarcoma
Myosarcoma
Histiocytic Sar...
Synovial Sarcom...
Lymphangiosarco...
Malignant Perip...
Myxofibrosarcom...
Myxoid Liposarc...
Undifferentiate...
Pleomorphic Lip...
Undifferentiate...
Dedifferentiate...
Pleomorphic Rha...
Malignant Trito...
Sequential chem...
Hypofractionate...
18 Years - 100 Years Maria Sklodowska-Curie National Research Institute of Oncology View A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma NCT04996004 Leiomyosarcoma
Ontorpacept (TT...
Doxorubicin
18 Years - Pfizer View A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas NCT04906876 Sarcoma
Soft Tissue Sar...
Metastatic Sarc...
Undifferentiate...
Myxofibrosarcom...
Leiomyosarcoma
Liposarcoma
Angiosarcoma
Synovial Sarcom...
Rhabdomyosarcom...
Spindle Cell Sa...
High Grade Sarc...
Bone Sarcoma
Gemcitabine
Docetaxel
9-ING-41
10 Years - Brown University View Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery NCT02180867 Alveolar Soft P...
Angiomatoid Fib...
Atypical Fibrox...
Clear Cell Sarc...
Epithelioid Mal...
Epithelioid Sar...
Extraskeletal M...
Extraskeletal O...
Fibrohistiocyti...
Fibrosarcoma
Inflammatory My...
Intimal Sarcoma
Leiomyosarcoma
Liposarcoma
Liver Embryonal...
Low Grade Fibro...
Low Grade Myofi...
Malignant Cutan...
Malignant Perip...
Malignant Trito...
Mesenchymal Cho...
Myxofibrosarcom...
Myxoid Chondros...
Myxoinflammator...
Nerve Sheath Ne...
PEComa
Pericytic Neopl...
Plexiform Fibro...
Sclerosing Epit...
Skin Glomus Tum...
Stage IB Soft T...
Stage IIB Soft ...
Stage III Soft ...
Stage IV Soft T...
Synovial Sarcom...
Undifferentiate...
Doxorubicin
Doxorubicin Hyd...
Ifosfamide
Pazopanib
Pazopanib Hydro...
Radiation Thera...
Therapeutic Con...
2 Years - National Cancer Institute (NCI) View Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery NCT02180867 Alveolar Soft P...
Angiomatoid Fib...
Atypical Fibrox...
Clear Cell Sarc...
Epithelioid Mal...
Epithelioid Sar...
Extraskeletal M...
Extraskeletal O...
Fibrohistiocyti...
Fibrosarcoma
Inflammatory My...
Intimal Sarcoma
Leiomyosarcoma
Liposarcoma
Liver Embryonal...
Low Grade Fibro...
Low Grade Myofi...
Malignant Cutan...
Malignant Perip...
Malignant Trito...
Mesenchymal Cho...
Myxofibrosarcom...
Myxoid Chondros...
Myxoinflammator...
Nerve Sheath Ne...
PEComa
Pericytic Neopl...
Plexiform Fibro...
Sclerosing Epit...
Skin Glomus Tum...
Stage IB Soft T...
Stage IIB Soft ...
Stage III Soft ...
Stage IV Soft T...
Synovial Sarcom...
Undifferentiate...
Doxorubicin
Doxorubicin Hyd...
Ifosfamide
Pazopanib
Pazopanib Hydro...
Radiation Thera...
Therapeutic Con...
2 Years - National Cancer Institute (NCI) View Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma NCT05116800 Soft Tissue Sar...
Undifferentiate...
Myxofibrosarcom...
Leiomyosarcoma
Liposarcoma
Angiosarcoma
Synovial Sarcom...
Rhabdomyosarcom...
Spindle Cell Sa...
High Grade Sarc...
Bone Sarcoma
Osteosarcoma
Ewing Sarcoma o...
Gemcitabine
9-ING-41
Docetaxel
10 Years - Brown University View Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma NCT02601209 High Grade Sarc...
Metastatic Leio...
Metastatic Mali...
Metastatic Syno...
Metastatic Undi...
Metastatic Unre...
Myxofibrosarcom...
Recurrent Leiom...
Recurrent Malig...
Recurrent Synov...
Recurrent Undif...
Stage III Uteri...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IV Uterin...
Stage IVA Uteri...
Stage IVB Uteri...
Unresectable Le...
Pazopanib
Pazopanib Hydro...
Sapanisertib
18 Years - National Cancer Institute (NCI) View Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma NCT04420975 Leiomyosarcoma
Malignant Perip...
Myxofibrosarcom...
Pleomorphic Rha...
Resectable Dedi...
Resectable Soft...
Resectable Undi...
Soft Tissue Fib...
Spindle Cell Sa...
Stage I Retrope...
Stage I Soft Ti...
Stage IA Retrop...
Stage IA Soft T...
Stage IB Retrop...
Stage IB Soft T...
Stage II Retrop...
Stage II Soft T...
Stage III Retro...
Stage III Soft ...
Stage IIIA Retr...
Stage IIIA Soft...
Stage IIIB Retr...
Stage IIIB Soft...
Storiform-Pleom...
Synovial Sarcom...
Undifferentiate...
Undifferentiate...
Undifferentiate...
Undifferentiate...
Undifferentiate...
Definitive Surg...
Nanoplexed Poly...
Nivolumab
Radiation Thera...
18 Years - Jonsson Comprehensive Cancer Center View Alisertib in Treating Patients With Advanced or Metastatic Sarcoma NCT01653028 Myxofibrosarcom...
Recurrent Adult...
Recurrent Leiom...
Recurrent Lipos...
Recurrent Malig...
Recurrent Undif...
Stage III Soft ...
Stage IV Soft T...
Alisertib
Laboratory Biom...
18 Years - National Cancer Institute (NCI) View Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery NCT03009201 Advanced Soft T...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Metastatic Angi...
Metastatic Epit...
Metastatic Fibr...
Metastatic Lipo...
Metastatic Mali...
Metastatic Myxo...
Metastatic Soft...
Metastatic Syno...
Metastatic Undi...
Myxofibrosarcom...
Pleomorphic Rha...
Stage III Soft ...
Stage IV Soft T...
Undifferentiate...
Unresectable Le...
Unresectable Li...
Unresectable Ma...
Unresectable So...
Unresectable Sy...
Unresectable Un...
Doxorubicin Hyd...
Laboratory Biom...
Pharmacological...
Ribociclib
12 Years - OHSU Knight Cancer Institute View Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma NCT02584309 Sarcoma, Soft T...
Soft Tissue Sar...
Undifferentiate...
Leiomyosarcoma
Liposarcoma
Synovial Sarcom...
Myxofibrosarcom...
Angiosarcoma
Fibrosarcoma
Malignant Perip...
Epithelioid Sar...
Dexrazoxane
Doxorubicin
18 Years - Washington University School of Medicine View Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery NCT03009201 Advanced Soft T...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Metastatic Angi...
Metastatic Epit...
Metastatic Fibr...
Metastatic Lipo...
Metastatic Mali...
Metastatic Myxo...
Metastatic Soft...
Metastatic Syno...
Metastatic Undi...
Myxofibrosarcom...
Pleomorphic Rha...
Stage III Soft ...
Stage IV Soft T...
Undifferentiate...
Unresectable Le...
Unresectable Li...
Unresectable Ma...
Unresectable So...
Unresectable Sy...
Unresectable Un...
Doxorubicin Hyd...
Laboratory Biom...
Pharmacological...
Ribociclib
12 Years - OHSU Knight Cancer Institute View ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma NCT04480502 Undifferentiate...
Myxofibrosarcom...
Envafolimab
Ipilimumab
12 Years - Tracon Pharmaceuticals Inc. View A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma NCT04996004 Leiomyosarcoma
Ontorpacept (TT...
Doxorubicin
18 Years - Pfizer View A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg NCT04332874 Sarcoma
Myxofibrosarcom...
Undifferentiate...
Alveolar Soft P...
Isolated Limb I...
Pembrolizumab
infusion of mel...
12 Years - Memorial Sloan Kettering Cancer Center View Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas NCT04242238 Sarcoma
Advanced Sarcom...
High Grade Sarc...
Leiomyosarcoma
Undifferentiate...
Myxofibrosarcom...
Dedifferentiate...
DCC-3014
Avelumab
18 Years - Memorial Sloan Kettering Cancer Center View CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma NCT03425279 Undifferentiate...
Myxofibrosarcom...
CAB-AXL-ADC
PD-1 inhibitor
12 Years - BioAtla, Inc. View Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas NCT04242238 Sarcoma
Advanced Sarcom...
High Grade Sarc...
Leiomyosarcoma
Undifferentiate...
Myxofibrosarcom...
Dedifferentiate...
DCC-3014
Avelumab
18 Years - Memorial Sloan Kettering Cancer Center View Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery NCT03009201 Advanced Soft T...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Metastatic Angi...
Metastatic Epit...
Metastatic Fibr...
Metastatic Lipo...
Metastatic Mali...
Metastatic Myxo...
Metastatic Soft...
Metastatic Syno...
Metastatic Undi...
Myxofibrosarcom...
Pleomorphic Rha...
Stage III Soft ...
Stage IV Soft T...
Undifferentiate...
Unresectable Le...
Unresectable Li...
Unresectable Ma...
Unresectable So...
Unresectable Sy...
Unresectable Un...
Doxorubicin Hyd...
Laboratory Biom...
Pharmacological...
Ribociclib
12 Years - OHSU Knight Cancer Institute View Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall NCT03651375 Sarcoma
Fibrosarcoma
Leiomyosarcoma
Liposarcoma
Myosarcoma
Histiocytic Sar...
Synovial Sarcom...
Lymphangiosarco...
Malignant Perip...
Myxofibrosarcom...
Myxoid Liposarc...
Undifferentiate...
Pleomorphic Lip...
Undifferentiate...
Dedifferentiate...
Pleomorphic Rha...
Malignant Trito...
Sequential chem...
Hypofractionate...
18 Years - 100 Years Maria Sklodowska-Curie National Research Institute of Oncology View